Actively Recruiting
Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
Led by Shirley Ryan AbilityLab · Updated on 2024-07-24
40
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).
CONDITIONS
Official Title
Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of relapsing form of Multiple Sclerosis (including relapsing-remitting MS and secondary progressive MS)
- Able to walk independently overground
- Free from Multiple Sclerosis relapse for at least 1 month
- Age between 18 and 75 years
- If using dalfampridine, must have been on the same daily dose for at least 2 months before screening
You will not qualify if you...
- Orthopedic injuries, fractures, surgeries, or other conditions that affect walking or weight bearing
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shirley Ryan AbilityLab
Chicago, Illinois, United States, 60611
Actively Recruiting
Research Team
W
Weena Dee
CONTACT
A
Alex Barry
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here